BioSpace News Archive

BioForest

Naturopathic Doctors Offer Non-Drug Approaches to Manage HypertensionApproximately 103 Million American Adults Have High Blood Pressure

New guidelines from the American Heart Association mean that nearly one out of every two American adults with high blood pressure may be facing a choice about prescription drug treatment.

August 3, 2018
·
2 min read
Business

Savaria Announces Its 2018 Second Quarter Results Release Date

Savaria Corporation will release its 2018 second quarter results after market hours on August 8, 2018.

August 3, 2018
·
1 min read
BioCapital

Study Reveals Non-Emergency Medical Transportation (NEMT) is Extremely Cost-Effective and Life-Saving to Medicaid ProgramMore than $40 Million ROI Per Month Found in Study Population Alone

For more than 40 years, Medicaid beneficiaries, many of whom are among our nation’s most fragile citizens, have relied on non-emergency medical transportation (NEMT) for travel to and from medical appointments.

August 3, 2018
·
5 min read
Business

Immune Design Reports Second Quarter 2018 Financial Results and Provides Corporate Update

G100 advancing to late-stage development following FDA feedback

August 3, 2018
·
10 min read
Deals

BioCryst Pharmaceuticals Commences Public Offering of $50 Million of Its Common Stock

BioCryst Pharmaceuticals, Inc. announced that it is offering to sell $50 million of its common stock in an underwritten public offering.

August 3, 2018
·
3 min read
Business

PRA Health Sciences, Inc. Reports Second Quarter 2018 Results and Updates Full Year 2018 Guidance

Net new business of $670.0 million; Net book-to-bill of 1.30

August 3, 2018
·
28 min read
Policy

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MabVax, Farmland, and ACADIA, and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of MabVax Therapeutics Holdings, Inc., Farmland Partners Inc., and ACADIA Pharmaceuticals Inc.

August 3, 2018
·
2 min read
Deals

BioCryst Pharmaceuticals Prices Public Offering of 9,090,910 Shares of Its Common Stock

BioCryst Pharmaceuticals, Inc. announced the pricing of an underwritten public offering of 9,090,910 shares of its common stock, offered at a price to the public of $5.50 per share.

August 3, 2018
·
3 min read
Business

GrowLife, Inc. Reports Over 131% Year-Over-Year Revenue Growth in Second Quarter 2018 Financial Results and Operational Ramp-Up Highlights Update

GrowLife, Inc. announced financial results for the quarter ending June 30, 2018, and provided an overview of recent operational highlights.

August 3, 2018
·
6 min read
Business

ALGAE DYNAMICS CORP SECURES BULK CANNABIS SUPPLY AGREEMENT FOR COLLABORATION PARTNERS

ALGAE DYNAMICS CORP has secured a supply agreement to enable Canadian Licensed Producers and International Licensed Importers access to bulk cannabis deliveries in anticipation of licensing agreements for our proprietary Cannabis formulated products.

August 3, 2018
·
5 min read